Work

Concerto (NCT04409639): A Phase 2 Trial of Cobimetinib in Newly Diagnosed and HMA-Treated CMML Patients with RAS Pathway Mutations

FWCI: 0.469
Cites:
Cited by: 4
Related to: 10